FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to medical chemistry and pharmacology, and concerns an antitumour agent for treating prostate cancer in form of 2-sachet'-{[(E)-3β-hydroxy-androst-5-en-17-ylidene]methyl}-4',5'-dihydro-1',3'-oxazole, modified with oleic acid to obtain a pharmaceutical substance – (3S,10R,13S,E)-17-((4,5-dihydrooxazol-2-yl)methylene)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl oleate, wherein the antitumour agent additionally contains phospholipid and maltose in the following ratio of components: pharmaceutical substance: phospholipid: maltose 1:10:39.
EFFECT: use of the invention enables higher clinical effectiveness with reduced dose and reduced toxic effect on healthy tissues.
1 cl, 4 dwg, 5 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PREGN-17(20)-ENE DERIVATIVES WITH ANTITUMOR ACTIVITY | 2015 |
|
RU2617698C2 |
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
PHOSPHOLIPID COMPOSITION OF ECDISTEN EXHIBITING ADAPTOGENIC AND HEPATOPROTECTIVE ACTIVITY | 2013 |
|
RU2575561C2 |
METHOD OF COMBINED THERAPY FOR CONNECTIVE TISSUE SARCOMA M-1 IN RATS USING A CONJUGATE OF DIPROPOXYBACTERIOPURPURIN WITH DOXORUBICIN | 2023 |
|
RU2808909C1 |
ANTITUBERCULOUS COMPOSITION AND METHOD FOR PREPARING IT | 2011 |
|
RU2472512C1 |
METHOD FOR PRODUCING COMPOSITION FOR PHOTODYNAMIC THERAPY IN FORM OF PHOSPHOLIPID NANOPARTICLES BASED ON GLUCAMINE CHLORINE E6 SALT, MALTOSE AND PHOSPHATIDYLCHOLINE | 2014 |
|
RU2576025C1 |
PHARMACEUTICAL COMPOSITION BASED ON GLUCOCORTICOSTEROID BUDESONIDE AND PHOSPHATIDYLCHOLINE FOR DRY INHALATION | 2019 |
|
RU2730488C1 |
LIPID DERIVATIVE OF SARCOLYSIN IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2017 |
|
RU2662086C1 |
2-AMINOCHROMEN DERIVATIVES EXHIBITING ANTI-TUMOR ACTIVITY; PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2704262C1 |
ANTITUMOR REMEDY TAKEN PER OS AND METHOD FOR PRODUCING THE REMEDY | 2004 |
|
RU2292209C2 |
Authors
Dates
2019-07-23—Published
2018-06-05—Filed